Indications for use
All news |
A Novelty on the Veterinary Market from Arterium Corporation
Arterium Has Expanded Its Product Range and Redesigned the Dioflan Drug Package
Arterium Brings a New Product of Endocrinological Profile to Ukrainian Market
Active substance: nifuroxazide
How supplied Coated tablets 0.2 g №10.
active substance: nifuroxazide;
composition per 1 tablet: 200 mg of nifuroxazide, equivalent to 100% substance;
excipients: microcrystalline cellulose; povidone, lactose, monohydrate, calcium stearate, coating mixture «Opadry II Yellow» 33G22623, containing: hypromellose, lactose monohydrate, titanium dioxide (E 171), polyethylene glycol 3000 (macrogol), triacetin; quinoline yellow (E 104); Sunset Yellow FCF (E 110), iron oxide yellow (E 172); indigo carmine (E 132).
Infectious diarrhea in children and adults, chronic colitis, enterocolitis, as an adjunctive treatment in combined therapy of intestinal dysbiosis.
Hypersensitivity to 5-nitrofurane derivatives and/or other components of the drug.
Dosage and administration
Nifuroxazide should be taken orally, with or without meals.
Adults and children over 6 years of age - 1 tablet 4 times daily (a daily dose - 800 mg).
The treatment course is 5 - 7 days.
Nifuroxazide is well tolerated; however, the following effects may be occasionally observed:
gastrointestinal disorders: short-term abdominal pain, nausea, aggravation of diarrhea.
Hypersensitivity reactions (require discontinuation of the drug):
respiratory disorders: asthma;
skin disorders: rash, pruritus.
Copyright 2015 ARTERIUM
Created by World Web Studio